Cytokines, implantation and early abortion: re-examining the Th1/Th2 paradigm leads to question the single pathway, single therapy concept
INTRODUCTION
The low success rate of implantation in humans is a long-standing problem for assisted reproductive medicine. The economic problems and psychological constraints linked to the necessity of undergoing multiple attempts before obtaining a successful pregnancy are a continuous worry for both medical practitioners and economists. Furthermore, the low rate of human implantation is certainly a recurring problem for preimplantation genetic diagnosis procedures, as once selected the odds of a genetically correct embryo resulting in a successful pregnancy remains limited. Again, here the economic and psychological consequences are evident. Finally, and most importantly for this paper, there exist a certain number of women for whom despite repeated successful in vitro fertilization, the embryo transfers always fail. This failure may be due to either a defect of implantation [no human chorionic gonadotrophin (hCG) production is ever detected, Ôoccult pregnancy lossÕ] or occur after a transient detection of hCG production following which one observes an immediate drop of hormone levels testifying to early pregnancy loss. These very early pregnancy losses are likely to differ from a constitutive abortion, and even recurrent immediate post implantation failures are likely to differ from recurrent spontaneous abortion. In fact, as the implan-tation rate is low in humans, compared with other species, this may even be a physiological aspect of human pregnancy. 1 It has now been proposed to use lymphocyte immunotherapy (IT) for the treatment of implantation defects. One of the rationales for IT is the T helper cell type 1/2 (Th1/Th2) paradigm: it is thought that there is an involvement of excess Th1 cytokine production in implantation failure. IT is viewed as acting to correct a Th1 imbalance, as well as dampening natural killer (NK) cells and as such should be a proper treatment for recurrent implantation failure.
We were asked to present our opinion about these topics at the last 2002 Chicago American Society of Reproductive Immunology meeting, and the paper here is a (non-exhaustive) summary of the reasons why we think that: (i) implantation failures are not dependent on a single aetiology; (ii) as such each individual is not likely to be treated successfully by a single treatment protocol; (iii) the Th1/Th2 paradigm is becoming obsolete and challenged by a variety of data.
Screening for gene defects will obviously be necessary. Two examples of such defects are:
(1) Complement regulatory proteins 2 and indoleamine 2,3-dioxygenase (IDO). 3 We are certain that deregulation of such molecules contribute to some cases of implantation failure or recurrent abortion, and that in the future screening of defects for their genes/production could be a part of molecular analysis of embryos to optimize embryo transfer. Thus, in humans, the regulation of decay accelerating factor 7 and membrane cofactor protein 8 needs obviously to be studied in detail. (2) Histocompatibility leukocyte antigen (HLA)-G embryonic production: there is a recent report that production of sHLA-G might be necessary (but not sufficient) for successful implantation. 4 What is the function of HLA-G remains uncertain, but it is not necessarily linked entirely to NK function.
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SOME IMMUNOLOGICAL PARAMETERS OF IMPLANTATION
If one intends to use a single treatment for implantation failure, one would have to justify it on the basis of what is known of implantation. The mechanisms are not the same as for established pregnancy:
(1) Implantation is an event depending on at least several steps that were identified several years before (see Fig. 1 ). We know little about the blastocyst orientation stage, but assisted hatching has been proposed by some to improve implantation rates. (2) We know that there is a continuous embryouterus interaction, and as the discovery of the Ôimplantation windowÕ, 9 the concept of Ôuterine receptivityÕ has emerged, with the idea that cytokines could be central in that process.
The steps that are known to involve immunological molecules are:
(1) Apposition/adhesion -At this stage induction of adhesion molecules and the proper ligands are critical steps. 10, 11, 12 Hence it is very important that the expression of receptors/ligands at the cell surface of the embryo and uterus coincide. There is an involvement of interleukins, but also an important hormonal regulation, both in the uterus and on the embryo. An example is colony stimulating factor (CSF)-1. 13, 14, 15 For the embryo, the group of Chandana Das in Delhi has recently, in cooperation with us, provided the first evidence that indeed hormones have profound effects on the proper secretion of interleukins by the embryo. 16 Adhesion molecules are also selectively regulated; 10, 11, 12 for example some chains of integrins are up regulated, others need down regulation. 11, 12 There is no systemic correlate of such regulation on peripheral blood lymphpocytes. 
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Given the complexity of these events, some molecules (among them interleukins) can have different effects, according to the step at which they are present. Furthermore, the Th1/Th2 paradigm would predict that inflammatory molecules are deleterious for implantation. This is certainly true for a certain number of pathologies with a key role for TNF. For such pre-existing ÔabnormalÕ inflammation, we have observed certain pathologies where administration of tocoopherol/torental is very efficient. 24 Such is also postulated by the Ôimmuno dystrophismÕ concept of Hill. 17, 18 The latter stems from earlier studies on murine abortion. 19 These studies led Tom Wegmann to propose the Th1/Th2 concept 20 that we proved relevant in mice in the post implantation period. 21 However, the phenomena happening in the implantation period itself were already known to be different from the post implantation period. 22, 23 The uterus post coitum until the apposition stage is the subject of an Ôinflammatory likeÕ reaction with a transient cellular influx near the uterine lumen of lymphocytes and macrophages. 22, 23 A signal present in seminal fluid seems to be required. 25 high levels of interleukin (IL)-a, IL-1b, TNF-a, IL-6 mRNAs are detected in the uterus, and the local production of CSF-1, which is a characteristic of pregnancy, starts by then.
This phase is very quickly followed by a return to basal levels of those cytokines, by days 3 and 4, safe except for the case of CSF-1. 25, 26 Disruption of such inflammatory events or their kinetics leads to implantation failure. In rats, local injection of BN 50081 (a platelet activating factor aceter antagonist) in a uterine horn prolongs the accumulation of lymphocytes in the uterine horn and completely prevents implantation, whereas the untreated contra lateral horn is fully receptive, 23 a fact contrary to the Th1/Th2 scheme.
Indeed, a certain number of inflammatory Th1 or Th1 like cytokines have been shown to be critical for implantation by knock out technologies or by use of antibody neutralization.
(1) Interleukin-11 -even if the initial experiments of Simon and Polan in mice 27 are controversial, there is clear cut evidence for an IL-1 autocrine/paracrine network in human. 28 (2) Interleukin-11 -receptor knock out mice do not implant because of an abnormal uterine response.
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(3) Leukaemia inhibitory factor (LIF) -an inflammatory molecule was the first molecule whose knock-out rendered mice sterile. 30 In humans, a group of sterile women had a lower production of LIF compared with a group of fertile women.
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FURTHER COMPLEXITY OF IMPLANTATION: SOME EXAMPLES
We started to investigate LIF in humans as soon as the first results in knock-out mice were published. At first it appeared to be a simple situation. When explants of uterine biopsies were cultured, we found that fertile women had a higher production of LIF as defined by LIF production index (LP) than those from women suffering from unexplained sterilities (Fertile: Median LIF production index: 3.22; Repeated implantation failure: Median LIF production index: 1.45). 31 Those data were confirmed by S. Laird using a different technique, 32 and others such as MF Piccini (Italy). However, there were two problems in those initial findings:
(1) As systemic production of LIF is normal, with no side effects on liver, osteoclasis, etc, the question of what does deregulate local LIF production remains unresolved. (2) Some sterile women had high levels of LIF, 31 which was expected as we believed (and still do so) that not all incidences of infertility are because of a LIF deregulation. An explanation could be the existence of pinpoint mutations that affect LIF protein activity. 33 But some fertile women had low levels of LIF, and in general. there was an overlapping between the groups. 31 Another explanation might reside in the complex regulation of LIF that is expressed as three isoforms with different specific activities and different tissue specific regulation. 34 Intracellular addressing/transport and thus final intracellular localization could also be important. The secretion of LIF is known to have various effects in other organs, whether it is secreted at the apical pole or basal pole of the glandular epithelium. We therefore investigated production towards either the uterine lumen or directed towards the uterine stroma. Indeed, after validating the flushing system, and using an enzyme linked immunosorbant assay (ELISA) which is highly sensitive and specific, we found that excess LIF in uterine flushings, e.g. detected in the lumen, on day 26 is highly predictive of pregnancy failure P ¼ 0.0013. (Fig. 2) . 35 Such an excess might in fact reflect a persistent pre-existing excess inflammation, as it correlates with excess IL-11, IL-8, CSF-1 (ELISAs) and TNF (bioassay) 35 and excess number of NKs (Fig. 3) .
The yet unsolved problem is whether excess luminal LIF is an indicator, as is likely, or a cause of the local deregulation. The latter hypothesis would be troublesome for cytokine replacement therapy as the dose of LIF or the route of administration could be critical. It is important to note that the studies of Stewart 30 in mice used an I.P. osmotic pump. These data show the precautions that will have to be applied when designing or even testing treatments for implantation failure.
Another example of the complexity resides in the regulation of IL-12. This cytokine has been shown to be abortifacient when co-injected with IL-18 by a Japanese group, 36 and later in a cell transfer system to induce abortion and a pre-eclampsia-like pathology. 37 IL-12 has two isoforms, one bioactive, the other not as active (although there is some controversy concerning that). The active heterodimer is upregulated during the resorption process in the CBA · DBA/2 model compared with the non-resorbing CBA · BALB/c mating. In contrast the total ÔpoolÕ of IL-12 is grossly unaffected. There is in fact slightly more P40 in the CBA · BALB/c system than in the CBA · DBA/2 system at the time. This shows that for this one cytokine regulation of biological activity is rather complex. Fig. 4 shows day 12.5 ELISAs (Zourbas et al, unpublished data).
Thus even for a single cytokine in the peri-and immediate post implantation period, fine isoform regulation can be very important. There are other examples of such complexity with regard to the individual regulation of each integrin chain 11, 12 ; these results were a surprise even for specialists in the field. 12 
LIMITS OF THE TH1/TH2 PARADIGM
Tom Wegmann first introduced the idea that the materno-foetal relationship was bidirectional and that immunostimulation might be more important than immunosuppression. 38 Studies of Arceci and Jeff Pollard on CSF-1 39,40 also drew interest on local production of cytokines. The second notion was to suggest that Ôallopregnancy is a Th2 phenomenonÕ, the Th1 cytokines being abortifacient, and the Th2 cytokines being protective. 20 This concept has been tested with success in mice, 21, 41, 42 and humans, 43, 44 albeit it was also almost immediately challenged in humans. 45 However, the concept did not predict a central role for NK cells, although the CBA · DBA/2 abortion model appeared at the time to be NK mediated 46, 47, 48 (to our surprise) with a possible minor but real role for the macrophages. 49, 50 The IDO model was the first model of T cell (CD4 T cells, not CD8) mediated abortion. 3 We now know that the uterine NK cells are crucial. 51 Furthermore, we know that they do not only play an important role in abortion, but can also have a positive role in implantation. NK cells, not T cells, seem to control IL-10 secretion by the placenta as a consequence of the alloimmunization process in the CBA · DBA/2 system, 52 and can themselves secrete IL-10 if properly triggered.
Indeed, NK cells present two distinct families of receptors, the engagement of one or the other [killer cell inhibitory receptor (KIR) versus killer cell activating receptor (KAR)] grossly determining their ÔinhibitionÕ versus ÔactivationÕ.
Even such a system is very complex. For example, Rajgopalan has recently demonstrated at the Cambridge NK and Reproduction Conference that engagement by HLA-G of a KIR receptor results in induction of gamma interferon secretion but not cytotoxicity, 53 and other examples of single receptors with dual functions have been reported. 54 Most importantly, for the CBA · DBA/2 system, the LY-49A receptor is sensitive to very fine major histocompatibility factor (MHC) mutations outside the binding grove. 55 Thus while the immunizing effects of the BALB/c · DBA/2 recombinant are because of an outside MHC antigen, 56 Ly49 could explain the importance of the MHC effect in this system, as members of the family can recognize discrete conformational variants such as those induced by binding of exogenous peptides from outside MHC or allosteric modifications. This suggestion was made by Wayne Yokohama at the 1998 INSERM NK and Reproduction Meeting.
The central role for NK cells in pregnancy has come from key experiments of Anne Croy. NK knock-out mice show important peri implantation defects and post implantation defects related to the vascular bed. 51, 57 It is therefore very important to know that uterine NK cells (uNK) do secrete the very important cytokine, angiopoı¨etin 2. 57, 73 The discrepancy with the mice uNK deficiency linked to absence of the common receptor gamma chain studied by Saito which have normal pregnancy remains, however, to be understood. 59 The present consensus points towards the NK as essential for pregnancy, and not simply deleterious. Also, uNK cells have a different phenotype and activities than peripheral NK cells.
Therefore,
(1) NK cell counts and activity in the periphery are poorly representative of local uNK activity. (2) 57, 58 . Thus, uNKs are then activated in implantation without induction of cytotoxicity, a mechanism we now know can be performed via certain receptors as mentioned above.
The Th1/Th2 paradigm did not predict the Ômissing selfÕ concept, 63 nor NK mediated immune control of vascularization. Besides, the paradigm:
(1) Is obviously established for a steady state pregnancy (It never considered kinetics such as the waves of transforming growth factor-b seen at the local level, for example, 64 the new cytokines in mice, 62, 63, 65 or even the cytokine profiles observed in human pregnancy at the systemic level. (2) Classifies the cytokines as Ôgood guysÕ (Th2) and bad guys (Th1). One of the most classical Ôbad guysÕ is gamma interferon that is indeed abortifacient at high doses, alone or in synergy with excess TNF. 19, 23 It then it affects the fgl2 prothrombinase system. 50, 67 But we now know that interferon at lower doses is also essential for successful pregnancy. 68 Another Ôbad guyÕ, TNF, is not merely that, but exerts a variety of functions that makes it pivotal for pregnancy. 69 (3) The paradigm does not take into consideration the new cytokines discovered as its enunciation: see the IL-10 family. 70 We therefore decided to launch an extensive longitudinal study of the Ônew cytokinesÕ, starting in order (it was only logical) with IL-11, IL-12, IL-13, IL-15 in the reproductive tract. We had already concluded Ôeven if one can generally distinguish pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines, other roles than involvement in the Th1/Th2 paradigm are to be notedÕ. 65 This assertion was confirmed when pursuing the study on IL-16, IL-17, and especially IL-18. 61, 62 We find an accumulation of IL-18 + uNK cells during the implantation period. Most importantly Ôwe find for IL-18 exactly the opposite pattern as what the Th1/Th2 paradigm would predict. IL-18 production was significantly lower in the decidua from the resorption prone mating than in the non-abortion prone mating. The deciduas or the placenta 62 by ELISA were measured by ELISA and has now been confirmed by real time polymerase chain reaction by Sasa Ostojiic in Rijeka (Fig. 5) .
Indeed, we believe that IL-18 patterns, just as IL-15 (which is a growth factor for uNK, but also regulates granzyme content of uNK) 71, 72 can be explained only by a concept that would integrate dual interactions of NK and T cells, (and NK cells with T cells). The role of immune cytokines in the control of angiogenesis, interactions of cytokines and receptors produced by the embryo on the uterus (not necessarily for immune functions) and vice versa, in a step by step controlled developmental process.
We do not deal with receptors but they also play a very important role. For example, the classical and pregnancy specific soluble TNF receptors are involved in parturition 73 and possibly in abortion. With that in mind, we decided to localize our present studies to the pre-implantation period in human. This combines the immunohistochemistry, flushing, and concentrating on IL-18 and IL-12 levels with NK counts by automated software. This is done after anti-CD56 labelling and an echographic evaluation of uterine status with focus on uterine vascular status using a common echographic score. We will briefly summarize the results, which will be published elsewhere.
STUDIES IN FERTILE VERSUS STERILE WOMEN
We first validated that the echographic score as defined in our Hospital was reproducible from cycle to cycle, which indeed it was (r ¼ 0.664, P ¼ 0.0016 between two cycles). We then compared two groups of women. The implantation failure group comprised women with normal ovarian reserve, and no history of pregnancy despite more that ten embryos transferred (n ¼ 37). The control group were fertile women followed in prenatal and pre-implantation diagnosis programs (n ¼ 3) and volunteers (n ¼ 6) (numbers in each group are now higher).
The control profile is strikingly homogeneous and characteristic (nine patients). They all show low or absent (glandular) IL-12, a neat glandular secretion of IL-18, luminal side, and discrete stromal spots of IL-18 secretion around the spiral arteries. Finally, CD56 uNK cells yields low to medium counts.
In the patients, 37 we see seven cases that are similar to the controls. This is not unexpected for us as it is unthinkable that all causes of sterility (infertility) could be due only to an IL-12/IL-18 related pathology (see above all the possibilities). Therefore, we believe that these women are representative of patients to be further explored by other assays such as ELISAs and microarray. In the remaining patients of the infertile group, one can distinguish four profiles. The first profile is characterized by an abnormal localization (stromal instead of glandular) and a high production there (dense immunohistochemistry labelling) of IL-18 (n ¼ 5). The second profile shows a high glandular secretion of IL-12, more intense than that of IL-18 (n ¼ 9). The third profile is characterized by high to very high counts of uNK cells (n ¼ 8) (Fig. 6 shows the various distributions observed, and their dispersion all along the stroma). Another subset of infertile patients is characterized by a complete depletion of cytokines (n ¼ 8). One can eventually simplify and distinguish two groups of infertile patients by reclassifying them bases on cytokines and cell excess, and the cytokine depletion on the other hand.
However, it is likely that by testing for other cytokines, insight into the real activation status of NKs (not only activation markers, but what they do secrete) will uncover further complexity among infertile patients. Of marked interest (Fig. 7) nevertheless is the fact that the abnormal cytokine profiles correlate with vascular anomalies as expressed by vascular score, suggesting indeed that the prime determinant of proper implantation is proper vascularization.
We therefore believe that we have identified at least four distinct pathologic profiles, and their rationale, and it is logical to deduce that they correspond to different causes of implantation failure (see Fig. 8 ).
Therefore, if there are different causes of implantation failure in humans, therapy can not be unique but must be developed so as to correct specifically the aetiology. In addition, case specific positive diagnosis or exclusion diagnosis is obviously required.
Also, the concept that inflammatory cytokines and Th1 molecules are crucial for some steps in the process is self-evident. We are sure that the complexity of the network will lead to the discovery of many examples of specific deregulation, each one very precise. The Th1/Th2 paradigm, as useful as it has been, cannot be used as a general explanation any longer, and is peculiarly irrelevant for implantation.
Finally, from what we know now, an alloimmunization might worsen some cases of implantation failure. For example, Poly IC or Poly IC12u (double stranded RNA, which are activators of NK cells) treated mice have an high abortion rate, which is dose dependent and allopregnancy status dependent, and this treatment is countered partly by alloimmunization 74, 75 . Poly IC induced sterility is reversible, depending on the dose used, within 3 weeks to 2 months. In certain strains, and at certain doses the mice that are both poly IC treated and alloimmunized, show an irreversible sterility (as expectable and expected). In certain other strains alloimmunization apparently strangely (but there is a logic!) can partially prevent the high rate of resorbtion, but instead of a return to normal status the residual lower 
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rate of resorbtion persists. This happens in both cases to be the mice pre-challenged by paternal strain or third party lymphocytes. (Chaouat G., unpublished data). Other animal models will be presented in due time. Therefore, we believe that the consequences of the new data are self evident as far as the application of IT to implantation is concerned. 
